Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney)

PHASE3RecruitingINTERVENTIONAL

Enrollment

570

Participants

Timeline

Start Date

August 20, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

December 1, 2026

Conditions

Alzheimer's Dementia

Interventions

DRUG

Wujia Yizhi granules

Drug: Wujia Yizhi granuless

DRUG

Placebo

Trial Locations (1)

RECRUITING

Fujian Medical University Affiliated Union Hospital, Fuzhou

All Listed Sponsors

lead

Sichuan Jishengtang Pharmaceutical Co., Ltd.

INDUSTRY